Statement Of Changes In Equity [Abstract]

Ascelia Pharma - Filing #689421

Concept	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Increase (decrease) through exercise of warrants, equity	– SEK	– SEK	– SEK	– SEK	– SEK	– SEK	– SEK	– SEK	482,000 SEK	– SEK	3 853 SEK	3 371 SEK	3 853 SEK	– SEK
Increase (decrease) through transactions with owners, equity	295,000 SEK	3 529 SEK	3 529 SEK	3 317 SEK	– SEK	– SEK	84,000 SEK	– SEK	5 879 SEK	– SEK	197 546 SEK	185 100 SEK	197 546 SEK	6 567 SEK
Share issue related cost	– SEK	84,000 SEK	84,000 SEK	– SEK	– SEK	– SEK	84,000 SEK	– SEK	– SEK	– SEK	13 271 SEK	13 271 SEK	13 271 SEK	– SEK